首页 | 本学科首页   官方微博 | 高级检索  
     

缺血性卒中静脉溶栓后症状性颅内出血研究进展
引用本文:梁志刚,杨绍婉,于国平. 缺血性卒中静脉溶栓后症状性颅内出血研究进展[J]. 中国卒中杂志, 2018, 13(12): 1301-1308. DOI: 10.3969/j.issn.1673-5765.2018.12.016
作者姓名:梁志刚  杨绍婉  于国平
作者单位:264000 烟台青岛大学附属烟台毓璜顶医院神经内科
基金项目:烟台市科技发展计划项目(2013WS022)烟台市重点研发项目(2018SFGY092)
摘    要:
出血转化,尤其症状性颅内出血是缺血性卒中患者急性期静脉溶栓后虽不常见但严重的并发症,其致残率和病死率均较高,严重影响患者预后。我国卒中急性期溶栓率远远落后于欧美国家,临床医生担心出血转化风险是主要原因。本文对溶栓后症状性颅内出血进行综述,以提高临床认识,更好地改进卒中急性期溶栓治疗。

关 键 词:缺血性卒中  静脉溶栓  症状性颅内出血  预测因素  治疗  
收稿时间:2018-04-25

Progress of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Ischemic Stroke
LIANG Zhi-Gang,YANG Shao-Wan,YU Guo-Ping. Progress of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Ischemic Stroke[J]. Chinese Journal of Stroke, 2018, 13(12): 1301-1308. DOI: 10.3969/j.issn.1673-5765.2018.12.016
Authors:LIANG Zhi-Gang  YANG Shao-Wan  YU Guo-Ping
Abstract:
Bleeding transformation, especially symptomatic intracranial hemorrhage is an
uncommon but serious complication after intravenous thrombolysis in the acute phase of ischemic
stroke, which can lead to high disability and mortality. Thrombolysis rate of acute stroke in
China was far lower than that in Europe and the United States, the main cause of which was for
fear of hemorrhagic transformation risk. This article reviewed the symptomatic hemorrhage after
thrombolysis, to provide a reference for safer thrombolytic therapy of acute stroke.
Keywords:Ischemic stroke,Intravenous thrombolysis,Symptomatic intracranial hemorrhage  Predictive factor,Treatment,
点击此处可从《中国卒中杂志》浏览原始摘要信息
点击此处可从《中国卒中杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号